Efficacy, Safety and Tolerability Study of Meloxicam Injection in Subjects After Abdominal Surgery

Pain, Post-operative Clinical Trial

Official title:
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Analgesic Efficacy, Safety and Tolerability of Meloxicam Injection in Subjects After Abdominal Surgery

Status Not yet recruiting

Clinical Trial Summary

The purpose of this study is to determine the analgesic efficacy and safety of Meloxicam Injection in subjects undergoing abdominal surgery.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05950152
Study type	Interventional
Source	Beijing Tide Pharmaceutical Co., Ltd
Contact	yangwen ou, medical doctor
Phone	0731-88618151
Email	ouyangwen139@126.com
Status	Not yet recruiting
Phase	Phase 2
Start date	July 2023
Completion date	February 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02284243` - Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy Surgery	Phase 2
Completed	`NCT02720692` - Evaluation of N1539 Following Major Surgery	Phase 3
Completed	`NCT03456141` - Multimodal Analgesic Protocol to Moderate Acute Pain
Terminated	`NCT02169336` - Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy	Phase 2
Completed	`NCT02675907` - Evaluation of N1539 Following Bunionectomy Surgery	Phase 3
Completed	`NCT02678286` - Evaluation of N1539 Following Abdominoplasty Surgery	Phase 3
Unknown status	`NCT01041313` - Memantine for Post-Operative Pain Control	Phase 4
Completed	`NCT02540265` - Placebo-Controlled Evaluation of N1539 Following Bunionectomy Surgery	Phase 2
Completed	`NCT03154658` - Serratus Anterior Plane Block in Patients Undergoing Mastectomy	Phase 4